Publication | Open Access
Yhhu3813 is a novel selective inhibitor of c-Met Kinase that inhibits c-Met-dependent neoplastic phenotypes of human cancer cells
16
Citations
20
References
2013
Year
Tumor BiologyC-met KinaseC-met-dependent Neoplastic PhenotypesMedicineCancer Cell BiologyCancer BiologyCancer TreatmentCancer GeneticsRadiation OncologyOncologyCell BiologyCancer ResearchNovel Selective Inhibitor
| Year | Citations | |
|---|---|---|
Page 1
Page 1